Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.

Translated title of the contribution: Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.

H.M. Lokhorst, I.G. Schmidt-Wolf, P. Sonneveld, B. van der Holt, H. Martin, R.M. Barge, U. Bertsch, J. Schlenzka, G.M.J. Bos, S. Croockewit, S. Zweegman, I. Breitkreutz, P. Joosten, C. Scheid, M. van Marwijk-Kooy, H-J. Salwender, M.H.J. van Oers, R. Schaafsma, R. Naumann, H. SinnigeI. Blau, M. Delforge, O. de Weerdt, P. Wijermans, S. Wittebol, U. Duersen, E. Vellenga, H. Goldschmidt, Ducht-Belgian HOVON German GMMG

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionThalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.
Original languageUndefined/Unknown
Pages (from-to)124-127
Number of pages4
JournalHaematologica
Volume93
Issue number1
Publication statusPublished - 2008

Cite this